Autopsy report · NCT00790296

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Interim analyses showed statistically and clinically significant results.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 11 months after it had already started.
Ran for about 3 years 3 months before it stopped.
11 participants enrolled.
Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: UConn Health
Sponsor type: University, hospital or other
Conditions: Cancer-related Fatigue
Interventions: Thyrotropin releasing hormone (TRH); Placebo
Participants: 11
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.